{"id":2,"date":"2018-07-10T19:03:59","date_gmt":"2018-07-10T19:03:59","guid":{"rendered":"http:\/\/tamuvetmed.wpengine.com\/safelab\/?page_id=2"},"modified":"2019-10-08T11:37:16","modified_gmt":"2019-10-08T16:37:16","slug":"sample-page","status":"publish","type":"page","link":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/","title":{"rendered":"Molecular and Cellular Oncology Lab"},"content":{"rendered":"<div class=\"button-group-flex count-4\"><a class=\"button\" href=\"\/cellular-oncology-lab\/activities\/\" target=\"\" rel=\"noopener noreferrer\">Activities<\/a> <a class=\"button\" href=\"\/cellular-oncology-lab\/people\/\" target=\"\" rel=\"noopener noreferrer\">People<\/a> <a class=\"button\" href=\"\/cellular-oncology-lab\/7-2\/\" target=\"\" rel=\"noopener noreferrer\">Publications<\/a> <a class=\"button\" href=\"\/cellular-oncology-lab\/research\/\" target=\"\" rel=\"noopener noreferrer\">Research<\/a><\/div>\n<p>Our studies are focused on developing new mechanism-based anticancer agents that target the Ah receptor, the nuclear receptors NR4A1, NR4A2 and NR4A3 and the Sp transcription factors. Research is also focused on long non-coding RNAs (lncRNAs) and their functions and on the roles of the Ah and NR4A receptors in mediating ligand-induced responses in non-tumor tissues.<\/p>\n<p>Our lab has characterized the role of several long non-coding RNAs in cancer development, including HOTTIP, HOTAIR in pancreatic cancer and those lncRNAs could be potential serum biomarkers and therapeutic targets. We also discovered the role of specificity protein transcription factors in cancer cells as non-oncogene addiction genes. In addition, we also identified the anticancer activity and its underlying mechanism of various small molecule compounds, such as sulindac sulfide, metformin, omeprazole, diindolylmethane analogs, phenethylisothiocyanate.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-101 size-fp-small\" src=\"http:\/\/tamuvetmed.wpengine.com\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-640x427.jpg\" alt=\"\" width=\"640\" height=\"427\" srcset=\"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-640x427.jpg 640w, https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-300x200.jpg 300w, https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-768x512.jpg 768w, https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-1024x683.jpg 1024w, https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-1200x800.jpg 1200w, https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-1920x1280.jpg 1920w\" sizes=\"auto, (max-width: 639px) 98vw, (max-width: 1199px) 64vw, 640px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Activities People Publications Research Our studies are focused on developing new mechanism-based anticancer agents that target the Ah receptor, the nuclear receptors NR4A1, NR4A2 and NR4A3 and the Sp transcription factors. Research is also focused on long non-coding RNAs (lncRNAs) and their functions and on the roles of the Ah and NR4A receptors in mediating [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-templates\/page-hero-buttons.php","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","_uag_custom_page_level_css":"","footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-2","page","type-page","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.3 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Home - Molecular &amp; Cellular Oncology Laboratory (Safe Lab)<\/title>\n<meta name=\"description\" content=\"Our studies are focused on developing new mechanism-based anticancer agents that target the Ah receptor, the nuclear receptors, and the Sp transcription factors.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Molecular and Cellular Oncology Lab\" \/>\n<meta property=\"og:description\" content=\"Activities People Publications Research Our studies are focused on developing new mechanism-based anticancer agents that target the Ah receptor, the\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/\" \/>\n<meta property=\"og:site_name\" content=\"Molecular &amp; Cellular Oncology Laboratory (Safe Lab)\" \/>\n<meta property=\"article:modified_time\" content=\"2019-10-08T16:37:16+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/tamuvetmed.wpengine.com\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-640x427.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/\",\"url\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/\",\"name\":\"Home - Molecular &amp; Cellular Oncology Laboratory (Safe Lab)\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/tamuvetmed.wpengine.com\\\/cellular-oncology-lab\\\/wp-content\\\/uploads\\\/sites\\\/27\\\/2019\\\/03\\\/safelabgroup-640x427.jpg\",\"datePublished\":\"2018-07-10T19:03:59+00:00\",\"dateModified\":\"2019-10-08T16:37:16+00:00\",\"description\":\"Our studies are focused on developing new mechanism-based anticancer agents that target the Ah receptor, the nuclear receptors, and the Sp transcription factors.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/#primaryimage\",\"url\":\"http:\\\/\\\/tamuvetmed.wpengine.com\\\/cellular-oncology-lab\\\/wp-content\\\/uploads\\\/sites\\\/27\\\/2019\\\/03\\\/safelabgroup-640x427.jpg\",\"contentUrl\":\"http:\\\/\\\/tamuvetmed.wpengine.com\\\/cellular-oncology-lab\\\/wp-content\\\/uploads\\\/sites\\\/27\\\/2019\\\/03\\\/safelabgroup-640x427.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Molecular and Cellular Oncology Lab\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/#website\",\"url\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/\",\"name\":\"Molecular &amp; Cellular Oncology Laboratory (Safe Lab)\",\"description\":\"Texas A&amp;M School of Veterinary Medicine &amp; Biomedical Sciences (VMBS)\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vetmed.tamu.edu\\\/cellular-oncology-lab\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Home - Molecular &amp; Cellular Oncology Laboratory (Safe Lab)","description":"Our studies are focused on developing new mechanism-based anticancer agents that target the Ah receptor, the nuclear receptors, and the Sp transcription factors.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/","og_locale":"en_US","og_type":"article","og_title":"Molecular and Cellular Oncology Lab","og_description":"Activities People Publications Research Our studies are focused on developing new mechanism-based anticancer agents that target the Ah receptor, the","og_url":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/","og_site_name":"Molecular &amp; Cellular Oncology Laboratory (Safe Lab)","article_modified_time":"2019-10-08T16:37:16+00:00","og_image":[{"url":"http:\/\/tamuvetmed.wpengine.com\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-640x427.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/","url":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/","name":"Home - Molecular &amp; Cellular Oncology Laboratory (Safe Lab)","isPartOf":{"@id":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/#primaryimage"},"image":{"@id":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/#primaryimage"},"thumbnailUrl":"http:\/\/tamuvetmed.wpengine.com\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-640x427.jpg","datePublished":"2018-07-10T19:03:59+00:00","dateModified":"2019-10-08T16:37:16+00:00","description":"Our studies are focused on developing new mechanism-based anticancer agents that target the Ah receptor, the nuclear receptors, and the Sp transcription factors.","breadcrumb":{"@id":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/#primaryimage","url":"http:\/\/tamuvetmed.wpengine.com\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-640x427.jpg","contentUrl":"http:\/\/tamuvetmed.wpengine.com\/cellular-oncology-lab\/wp-content\/uploads\/sites\/27\/2019\/03\/safelabgroup-640x427.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/"},{"@type":"ListItem","position":2,"name":"Molecular and Cellular Oncology Lab"}]},{"@type":"WebSite","@id":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/#website","url":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/","name":"Molecular &amp; Cellular Oncology Laboratory (Safe Lab)","description":"Texas A&amp;M School of Veterinary Medicine &amp; Biomedical Sciences (VMBS)","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"featured-small":false,"featured-medium":false,"featured-large":false,"featured-xlarge":false,"fp-small":false,"fp-medium":false,"fp-large":false,"fp-xlarge":false,"gform-image-choice-sm":false,"gform-image-choice-md":false,"gform-image-choice-lg":false,"rpwe-thumbnail":false,"web-stories-poster-portrait":false,"web-stories-publisher-logo":false,"web-stories-thumbnail":false},"uagb_author_info":{"display_name":"tamuvetmed","author_link":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/author\/tamuvetmed\/"},"uagb_comment_info":0,"uagb_excerpt":"Activities People Publications Research Our studies are focused on developing new mechanism-based anticancer agents that target the Ah receptor, the nuclear receptors NR4A1, NR4A2 and NR4A3 and the Sp transcription factors. Research is also focused on long non-coding RNAs (lncRNAs) and their functions and on the roles of the Ah and NR4A receptors in mediating&hellip;","_links":{"self":[{"href":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-json\/wp\/v2\/pages\/2","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-json\/wp\/v2\/comments?post=2"}],"version-history":[{"count":0,"href":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-json\/wp\/v2\/pages\/2\/revisions"}],"wp:attachment":[{"href":"https:\/\/vetmed.tamu.edu\/cellular-oncology-lab\/wp-json\/wp\/v2\/media?parent=2"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}